1、S-1/A 1 vc030_s1a.htm FORM S-1/A As filed with the Securities and Exchange Commission on December 5,2023.Registration No.333-272110 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 AMENDMENT NO.7 TOFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 Advanced Biomed Inc.(
2、Exact name of registrant as specified in its charter)Nevada 8071 87-2177170(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)689-87 Xiaodong Road,Yongkang DistrictTainan,TaiwanTel:886-6-3121716(Add
3、ress,including zip code,and telephone number,including area code,of registrants principal executive offices)Cogency Global Inc.122 East 42nd Street,18th FloorNew York,NY 10168(212)947-7200(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies of all com
4、munications to:Fang Liu,Esq.VCL Law LLP William S.Rosenstadt,Esq.Mengyi“Jason”Ye,Esq.1945 Old Gallows Road Ortoli Rosenstadt LLPSuite 260 366 Madison Avenue,3rd FloorVienna,VA 22182 New York,NY 10017Telephone:(703)919-7285 Telephone:(212)588-0022 Approximate date of commencement of proposed sale to
5、the public:As soon as practicable after the effective date of this registrationstatement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under theSecurities Act of 1933,check the following box:If this Form is filed to reg
6、ister additional securities for an offering pursuant to Rule 462(b)under the Securities Act,check thefollowing box and list the Securities Act registration statement number of the earlier effective registration statement for the sameoffering.If this Form is a post-effective amendment filed pursuant